title

Addiction Medicine: Beyond the Abstract

Shawn McNeil, MD

1
Followers
0
Plays
Addiction Medicine: Beyond the Abstract
Addiction Medicine: Beyond the Abstract

Addiction Medicine: Beyond the Abstract

Shawn McNeil, MD

1
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Hosted by the Journal Web Content Editor, Shawn McNeil, MD. These podcasts are an ideal opportunity for readers and others interested in addiction medicine to get a closer look at the perspectives behind formal research articles. Podcasts offer insights into the experiences of the authors and researchers behind the great work and development in the field. Listening to their stories and thought processes help listeners to connect with the experts behind the journal in a brand-new way.

Latest Episodes

Technology Use Among Patients in Inpatient Medically Managed Withdrawal

In episode fourteen of Addiction Medicine: Beyond the Abstract, we are joined byDr. Babak Tofighi. He is an assistant professor in the departments of medicine and population health at the NYU School of Medicine. In his recent article, Dr.Tofighidiscusses the use of technology-based interventions to optimize the treatment of substance use disorders (SUDs) and related comorbidities. To read more, click here.

12 MINOCT 8
Comments
Technology Use Among Patients in Inpatient Medically Managed Withdrawal

Opioid Agonist Treatment in Postpartum Period During Incarceration

In episode thirteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Jessica Gray. She is a family medicine physician and an addiction specialist in the departments of Medicine at Massachusetts General Hospital (MGH) and Pediatrics at Massachusetts General Hospital for Children (MGHfC). She is also Associate Program Director for the MGH Addiction Medicine Fellowship and Clinical Director of the HOPE Clinic at MGH. In her recent article, Dr. Gray discusses a case of a woman who was able to continue opioid agonist treatment during the postpartum period while she remained incarcerated, in a system that generally did not allow for opioid agonist treatment during incarceration except during pregnancy. To learn more, click here.

13 MINJUL 29
Comments
Opioid Agonist Treatment in Postpartum Period During Incarceration

Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs

In episode twelve of Addiction Medicine: Beyond the Abstract, we are joined byDr. HendréeJones, a professor in the Department of Obstetrics and Gynecology at the University of North Carolina and the Director of UNC Horizons Program. In her recent article, Dr.Jonesand her colleagues discuss the treatment of women in opioid use treatment programs in North Carolina and their utilization of reproductive and sexual health services. To read the article, click here.

11 MINMAY 29
Comments
Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs

Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)

In episode eleven of Addiction Medicine: Beyond the Abstract, we are joined byDr. Honora Englander,an Associate Professor of Medicine at Oregon Health & Science University and the Director and Principal Investigator of the Improving Addiction Care Team (IMPACT). In her recent article, Dr. Englander and her colleagues discuss using hospitalization as a "reachable moment" for highly vulnerable patients who are not engaged in treatment elsewhere and utilizing the IMPACT team in this process. To read more, click here.

13 MINAPR 10
Comments
Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

In episode ten of Addiction Medicine: Beyond the Abstract, we are joined byDr. Caleb Banta-Green,principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions aboutsubgroups that are more likely to take advantage of available interventions. Read more here.

12 MINMAR 13
Comments
Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

In episode nine of Addiction Medicine: Beyond the Abstract, we are joined byDr. John McCarthy, an associate professor of psychiatry and volunteer clinical faculty at the University of California Davis. In his recent study, Dr. McCarthy and his colleagues examined the significance of serum methadone/metabolite ratios (or MMRs). In particular, they looked at the changes in these ratios for the expecting mother throughout pregnancy and sought to use these ratios toobjectively guide methadone dosing. To read the full article, click here.

11 MIN2018 NOV 27
Comments
Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

Buprenorphine Treatment for Adolescents and Young Adults

In episode eight of Addiction Medicine: Beyond the Abstract, we are joined byDr. Lisa Marsch. She is a professor at Dartmouth and Director of both theCenter for Technology and Behavioral Health and the Dartmouth Psychiatric Research Center. In her recent study, Marsch and her colleagues took a look atrelevant randomized controlled trials and observational studies whichevaluated the use of buprenorphine in adolescents and young adults. To learn more, click here.

11 MIN2018 SEP 6
Comments
Buprenorphine Treatment for Adolescents and Young Adults

Nicotine Content in E-cigarette liquid: often not as labeled

In episode seven of Addiction Medicine: Beyond the Abstract, we are joined byBarrett Raymond. He is a nurse practitioner and graduate of Brigham YoungUniversity. In his recent study, Raymond analyzed e-cigarette liquid samples from popular online manufacturers and distributors in the United States. He compared the expected nicotine content with the measured levels. He also discussed regulatory changes and the potential impact on the industry. To read the full article, click here.

13 MIN2018 JUN 30
Comments
Nicotine Content in E-cigarette liquid: often not as labeled

Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

In episode six of Addiction Medicine: Beyond the Abstract, we are joined byKelly Moore, Ph.D.of Yale University School of Medicine. Her new study takes a look at the implementation of continued methadone maintenance treatment (MMT) upon incarceration. Often, inmates undergo forced withdrawal once they are placed in a correctional setting. Her study sought to measure the difference inbehavior both during incarceration and after release for inmates in amethadonemaintenancegroup compared to those in a forced withdrawal group. To read the article, click here.

11 MIN2018 MAY 16
Comments
Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

In episode five of Addiction Medicine: Beyond the Abstract, we are joined by Leo Beletsky, JD, MPHof Northeastern University. His commentary from the latest issue of the journal addresses common challenges that influence the delivery of substance use treatment in the primary care setting. He details underlying concepts of behavioral economics that may impact the decisions made by healthcare providers. Specifically, he addresses choice architecture as it relates to decisions regarding substance use treatment. Read more here.

14 MIN2018 APR 3
Comments
Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

Latest Episodes

Technology Use Among Patients in Inpatient Medically Managed Withdrawal

In episode fourteen of Addiction Medicine: Beyond the Abstract, we are joined byDr. Babak Tofighi. He is an assistant professor in the departments of medicine and population health at the NYU School of Medicine. In his recent article, Dr.Tofighidiscusses the use of technology-based interventions to optimize the treatment of substance use disorders (SUDs) and related comorbidities. To read more, click here.

12 MINOCT 8
Comments
Technology Use Among Patients in Inpatient Medically Managed Withdrawal

Opioid Agonist Treatment in Postpartum Period During Incarceration

In episode thirteen of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Jessica Gray. She is a family medicine physician and an addiction specialist in the departments of Medicine at Massachusetts General Hospital (MGH) and Pediatrics at Massachusetts General Hospital for Children (MGHfC). She is also Associate Program Director for the MGH Addiction Medicine Fellowship and Clinical Director of the HOPE Clinic at MGH. In her recent article, Dr. Gray discusses a case of a woman who was able to continue opioid agonist treatment during the postpartum period while she remained incarcerated, in a system that generally did not allow for opioid agonist treatment during incarceration except during pregnancy. To learn more, click here.

13 MINJUL 29
Comments
Opioid Agonist Treatment in Postpartum Period During Incarceration

Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs

In episode twelve of Addiction Medicine: Beyond the Abstract, we are joined byDr. HendréeJones, a professor in the Department of Obstetrics and Gynecology at the University of North Carolina and the Director of UNC Horizons Program. In her recent article, Dr.Jonesand her colleagues discuss the treatment of women in opioid use treatment programs in North Carolina and their utilization of reproductive and sexual health services. To read the article, click here.

11 MINMAY 29
Comments
Integrating Reproductive and Sexual Health Services for Women in Opioid Treatment Programs

Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)

In episode eleven of Addiction Medicine: Beyond the Abstract, we are joined byDr. Honora Englander,an Associate Professor of Medicine at Oregon Health & Science University and the Director and Principal Investigator of the Improving Addiction Care Team (IMPACT). In her recent article, Dr. Englander and her colleagues discuss using hospitalization as a "reachable moment" for highly vulnerable patients who are not engaged in treatment elsewhere and utilizing the IMPACT team in this process. To read more, click here.

13 MINAPR 10
Comments
Hospital-Based Addiction Care: The Improving Addiction Care Team (IMPACT)

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

In episode ten of Addiction Medicine: Beyond the Abstract, we are joined byDr. Caleb Banta-Green,principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions aboutsubgroups that are more likely to take advantage of available interventions. Read more here.

12 MINMAR 13
Comments
Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

In episode nine of Addiction Medicine: Beyond the Abstract, we are joined byDr. John McCarthy, an associate professor of psychiatry and volunteer clinical faculty at the University of California Davis. In his recent study, Dr. McCarthy and his colleagues examined the significance of serum methadone/metabolite ratios (or MMRs). In particular, they looked at the changes in these ratios for the expecting mother throughout pregnancy and sought to use these ratios toobjectively guide methadone dosing. To read the full article, click here.

11 MIN2018 NOV 27
Comments
Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

Buprenorphine Treatment for Adolescents and Young Adults

In episode eight of Addiction Medicine: Beyond the Abstract, we are joined byDr. Lisa Marsch. She is a professor at Dartmouth and Director of both theCenter for Technology and Behavioral Health and the Dartmouth Psychiatric Research Center. In her recent study, Marsch and her colleagues took a look atrelevant randomized controlled trials and observational studies whichevaluated the use of buprenorphine in adolescents and young adults. To learn more, click here.

11 MIN2018 SEP 6
Comments
Buprenorphine Treatment for Adolescents and Young Adults

Nicotine Content in E-cigarette liquid: often not as labeled

In episode seven of Addiction Medicine: Beyond the Abstract, we are joined byBarrett Raymond. He is a nurse practitioner and graduate of Brigham YoungUniversity. In his recent study, Raymond analyzed e-cigarette liquid samples from popular online manufacturers and distributors in the United States. He compared the expected nicotine content with the measured levels. He also discussed regulatory changes and the potential impact on the industry. To read the full article, click here.

13 MIN2018 JUN 30
Comments
Nicotine Content in E-cigarette liquid: often not as labeled

Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

In episode six of Addiction Medicine: Beyond the Abstract, we are joined byKelly Moore, Ph.D.of Yale University School of Medicine. Her new study takes a look at the implementation of continued methadone maintenance treatment (MMT) upon incarceration. Often, inmates undergo forced withdrawal once they are placed in a correctional setting. Her study sought to measure the difference inbehavior both during incarceration and after release for inmates in amethadonemaintenancegroup compared to those in a forced withdrawal group. To read the article, click here.

11 MIN2018 MAY 16
Comments
Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

In episode five of Addiction Medicine: Beyond the Abstract, we are joined by Leo Beletsky, JD, MPHof Northeastern University. His commentary from the latest issue of the journal addresses common challenges that influence the delivery of substance use treatment in the primary care setting. He details underlying concepts of behavioral economics that may impact the decisions made by healthcare providers. Specifically, he addresses choice architecture as it relates to decisions regarding substance use treatment. Read more here.

14 MIN2018 APR 3
Comments
Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles
hmly
himalayaプレミアムへようこそ聴き放題のオーディオブックをお楽しみください。